secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2024-08-28T23:59:59+00:00
Accession:  0001213900-24-073437
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Delisting extension and massive warrant dilution for Bluejay Diagnostics (BJDX); authorized shares up to 250M
--------------------------------------------------------------------------------

- Nasdaq extended compliance deadline to Feb 24, 2025; stock must close at $1.00+ for 10 days.
- Stockholders approved increase in authorized common shares from 50M to 250M.
- Class D warrants exercisable for ~21.5M shares at $0.0001; 6.6M shares issued so far.
- Class C warrants exercise price reset from $1.96 to $0.326, increasing potential dilution.
- Outstanding shares as of Aug 27: 12.85M; significant dilution expected from warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024073437/0001213900-24-073437-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024073437/ea0212465-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-073437

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer